CompoAtlas

VENTRE OK

Food supplement declared in France, declaration No 2022-10-107, decision dated 4 October 2022

VENTRE OK (Shenti) is a food supplement declared in France. Status: déclaré en France, commercialisation possible : l'administration ne s'est pas opposée à la déclaration (ce n'est ni une autorisation ni une évaluation de sécurité). 1 point in its composition requires a check (prohibited substance, dose or novel food).

Brand
Shenti
Food business operator placing the product on the market
Phytocomm Luxembourg sàrl
Status
Déclaré en France, commercialisation possible : l'administration ne s'est pas opposée à la déclaration (ce n'est ni une autorisation ni une évaluation de sécurité)
Form
Comprimé
Daily dose
9g / 3x6 comprimés
Not recommended for (according to the manufacturer)
Femmes enceintes, Sous anticoagulants, Enfants (de moins de 6 ans)
Objectives stated by the manufacturer (these are not authorised claims)
Digestion

Declaration 327319, procedure Article 16. Compl'Alim, food supplement declarations (France), retrieved 23 October 2026.

Regulatory points

Declared composition

Plants

PlantPartPreparationPer day
Atractylodes macrocephala Koidz.RacineExtrait sec aqueux3,396 mg
Paeonia lactiflora Pall.RacineExtrait sec aqueux2,250 mg
Citrus reticulata BlancoEssence (épicarpe, zeste)Extrait sec aqueux1,698 mg
Saposhnikovia divaricata (Turcz.) SchischkRacineExtrait sec aqueux1,146 mg
Zingiber officinale RoscoeRacineExtrait sec aqueux509 mg

List from the declaration, administrative decision dated (Compl'Alim, food supplement declarations (France)).

List recorded in 2022. Photograph the packaging to check whether it has changed. Photograph the packaging

This information reproduces the manufacturer's declaration to the administration (DGAL). It does not say whether the product is effective and does not replace advice from a doctor or pharmacist, particularly during pregnancy or when taking medication.

Brand : Shenti

List recorded in 2022. Photograph the packaging to check whether it has changed.

Enter to analyse, Shift+Enter for a new line